title: Revisiting the role of radical surgery in early stage prostate cancer.
abstract: Is it time to walk the line between overtreating indolent disease and undertreating aggressive disease?
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Costello
authors.forename: Niall M
authors.initials: NM
authors.lastname: Corcoran
authors.forename: Scott
authors.initials: S
authors.lastname: Van Appledorn
mesh_terms: D000367:Age Factors; D000368:Aged; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000639:trends*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D017430:Prostate-Specific Antigen